Cirrhosis: Difference between revisions

Line 2: Line 2:


===Differential===
===Differential===
* [[Hepatitis]] chronic B and C
* Alcoholic liver disease
* Non-alcoholic steatohepatitis
* Drug induced (ie. [[Tylenol]])
* Cardiac Cirrhosis
* Primary biliary cirrhosis
* [[Primary sclerosing cholangitis]]
* Autoimmune Hepatitis
* Alpha1 anti-trypsin Deficiency
* Cystic Fibrosis


===Clinical Features===
===Clinical Features===

Revision as of 17:39, 15 June 2016

Background

Differential

  • Hepatitis chronic B and C
  • Alcoholic liver disease
  • Non-alcoholic steatohepatitis
  • Drug induced (ie. Tylenol)
  • Cardiac Cirrhosis
  • Primary biliary cirrhosis
  • Primary sclerosing cholangitis
  • Autoimmune Hepatitis
  • Alpha1 anti-trypsin Deficiency
  • Cystic Fibrosis

Clinical Features

Child-Pugh Classification for Cirrhosis Mortality

+1 +2 +3
Bilirubin <2 mg/dL 2-3 mg/dL >3 Mg/dL
Albumin >3.5 mg/dL 2.8-3.5 mg/dL <2.8 mg/dL
INR <1.7 1.7-2.2 >2.2
Ascites No ascites Ascites, medically controlled Ascites, poorly controlled
Encephalopathy No encephalopathy Encephalopathy, medically controlled Encephalopathy, poorly controlled
  • Score ≤ 7 = Class A = 100% and 85% one and two-year patient survival
  • Score 7 - 9 = Class B = 80% and 60% one and two-year patient survival
  • Score ≥ 10 = Class c = 45% and 35% one and two-year patient survival


MELD-Na Score (Model End Stage Liver Disease)

MELD-Na Score 3-month mortality
40 71.3%
30-39 52.6%
20-29 19.6%
10-19 6.0%
<9 1.9%

Management

Disposition